Categorie > Lymphoma / Leukemia

Leukemia is a Type of Cancer

Categorie : Lymphoma / Leukemia
Leukemia is a certain type of cancer. Cancer is a disease that causes cells to become abnormal. ...

read more Leukemia is a certain type of cancer. Cancer is a disease that causes cells to become abnormal. read more Fri Mar 2010

Categorie : Lymphoma / Leukemia
Ever since Cancer has been around, there have been people who have been researching to find its cure. Dr. Tullio Simoncini is one person who has advanced the knowledge, theories, and cures behind all types of cancer for many decades. Here is some information on Dr. Simoncini, and his efforts to find ...

read more Ever since Cancer has been around, there have been people who have been researching to find its cure. Dr. Tullio Simoncini is one person who has advanced the knowledge, theories, and cures behind all types of cancer for many decades. Here is some information on Dr. Simoncini, and his efforts to find read more Fri Mar 2010

Researchers May Have Found the Leukemia Cause

Categorie : Lymphoma / Leukemia
A new study may shed light into why leukemia, one of the deadliest cancers, develops in the first place. Although leukemia is one of the best studied cancers, the cause of some types is still poorly understood, but experts in the US say a new method may make it possible for healthcare experts to dis ...

read more A new study may shed light into why leukemia, one of the deadliest cancers, develops in the first place. Although leukemia is one of the best studied cancers, the cause of some types is still poorly understood, but experts in the US say a new method may make it possible for healthcare experts to dis read more Fri Mar 2010

Donating Bone Marrow

Categorie : Lymphoma / Leukemia
Consider becoming a bone marrow donor. Most donations involve a simple blood stem cell draw similar to a transfusion, which is an outpatient procedure that could save a life! ...

read more Consider becoming a bone marrow donor. Most donations involve a simple blood stem cell draw similar to a transfusion, which is an outpatient procedure that could save a life! read more Fri Mar 2010

The Lowdown on Leukemia

Categorie : Lymphoma / Leukemia
Leukemia is a type of cancer that is characterized by an abnormal number of white blood cells. It can be diagnosed with a blood test and treated with chemotherapy, drug therapy, or a bone marrow transplant. ...

read more Leukemia is a type of cancer that is characterized by an abnormal number of white blood cells. It can be diagnosed with a blood test and treated with chemotherapy, drug therapy, or a bone marrow transplant. read more Fri Mar 2010

10 Warning Signs of Leukemia and Why You Need to Know Them

Categorie : Lymphoma / Leukemia
It is important that you know what warning signs of leukemia to check for especially if you have children. The acute type of leukemia is most common among children and is very deadly because it progresses very fast. Leukemia signs include loss of appetite, anemic look and more. ...

read more It is important that you know what warning signs of leukemia to check for especially if you have children. The acute type of leukemia is most common among children and is very deadly because it progresses very fast. Leukemia signs include loss of appetite, anemic look and more. read more Fri Mar 2010

EntreMed Receives Orphan Drug Designation For ENMD-2076 In Leukemia

Categorie : Lymphoma / Leukemia
EntreMed, Inc. (Nasdaq: ENMD), announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML)... ...

read more EntreMed, Inc. (Nasdaq: ENMD), announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML)... read more Fri Mar 2010

Discovery Of Genetic Link To Leukemias With An Unknown Origin

Categorie : Lymphoma / Leukemia
Although leukemia is one of the best studied cancers, the cause of some types is still poorly understood. Now, a newly found mutation in acute myeloid leukemia patients could account for half of the remaining cases of adult acute leukemia with an unknown origin... ...

read more Although leukemia is one of the best studied cancers, the cause of some types is still poorly understood. Now, a newly found mutation in acute myeloid leukemia patients could account for half of the remaining cases of adult acute leukemia with an unknown origin... read more Fri Mar 2010

Karolinska Development: EMEA Recommends Orphan Drug Designation For Acute Myeloid Leukemia Treatment

Categorie : Lymphoma / Leukemia
The European Medicines Agency (EMEA) recommends orphan drug status for Aprea's treatment of acute myeloid leukemia (AML). The treatment is currently undergoing a Phase I clinical study and a final decision from the European Commission regarding status is expected in a few weeks. Aprea is part of the ...

read more The European Medicines Agency (EMEA) recommends orphan drug status for Aprea's treatment of acute myeloid leukemia (AML). The treatment is currently undergoing a Phase I clinical study and a final decision from the European Commission regarding status is expected in a few weeks. Aprea is part of the read more Fri Mar 2010

FDA Approves Rituxan To Treat Chronic Lymphocytic Leukemia

Categorie : Lymphoma / Leukemia
The U.S. Food and Drug Administration approved Rituxan (rituximab) to treat certain patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow cancer. Rituxan, an anti-cancer drug, is intended for patients with CLL who are beginning chemotherapy for the first time ...

read more The U.S. Food and Drug Administration approved Rituxan (rituximab) to treat certain patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow cancer. Rituxan, an anti-cancer drug, is intended for patients with CLL who are beginning chemotherapy for the first time read more Fri Mar 2010

Large-Scale Study Reveals DNA Segments Missing Or Duplicated In Tumors, Uncovers Novel Cancer Genes And Genetic Abnormalities Shared Across Cancer

Categorie : Lymphoma / Leukemia
An international team of researchers has created a genome-scale map of 26 different cancers, revealing more than 100 genomic sites where DNA from tumors is either missing or abnormally duplicated compared to normal tissues. The study, the largest of its kind, finds that most of these genetic abnorma ...

read more An international team of researchers has created a genome-scale map of 26 different cancers, revealing more than 100 genomic sites where DNA from tumors is either missing or abnormally duplicated compared to normal tissues. The study, the largest of its kind, finds that most of these genetic abnorma read more Fri Mar 2010

Novartis Drug Tasigna® Receives FDA Priority Review For Newly Diagnosed Patients With Early-stage Chronic Myeloid Leukemia

Categorie : Lymphoma / Leukemia
Novartis announced that Tasigna® (nilotinib) has been granted priority review by the US Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase... ...

read more Novartis announced that Tasigna® (nilotinib) has been granted priority review by the US Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase... read more Fri Mar 2010

US FDA Approves Rituxan/MabThera For The Most Common Type Of Adult Leukemia

Categorie : Lymphoma / Leukemia
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) approved Rituxan/MabThera (rituximab) plus fludarabine and cyclophosphamide (FC) chemotherapy for people with either previously untreated (first-line) or previously treated (relapsed or refractory) CD20-posit ...

$read more Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) approved Rituxan/MabThera (rituximab) plus fludarabine and cyclophosphamide (FC) chemotherapy for people with either previously untreated (first-line) or previously treated (relapsed or refractory) CD20-posit$ read more Fri Mar 2010

Novartis Drug Tasigna(R) Receives FDA Priority Review For Newly Diagnosed Patients With Early-Stage Chronic Myeloid Leukemia

Categorie : Lymphoma / Leukemia
Novartis announced that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase... ...

read more Novartis announced that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase... read more Fri Mar 2010

FDA Approves Rituxan Plus Chemotherapy For The Most Common Type Of Adult Leukemia

Categorie : Lymphoma / Leukemia
Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untre ...

read more Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untre read more Fri Mar 2010

New Cancer-Fighting Strategy Focuses On Signaling Molecules

Categorie : Lymphoma / Leukemia
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors. The findings center on discovery of signaling molecules that are major players in a biochemical mechanism linking certain actions of B cells to solid tumor g ...

read more Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors. The findings center on discovery of signaling molecules that are major players in a biochemical mechanism linking certain actions of B cells to solid tumor g read more Fri Mar 2010

Mathematical Model Gives New Hope To Chronic Myeloid Leukaemia Patients

Categorie : Lymphoma / Leukemia
Doctors can now understand better chronic myeloid leukaemia (CML), including how it responds to therapy, thanks to a new mathematical model for the disease, developed by scientists in Portugal, Belgium and the United States... ...

read more Doctors can now understand better chronic myeloid leukaemia (CML), including how it responds to therapy, thanks to a new mathematical model for the disease, developed by scientists in Portugal, Belgium and the United States... read more Fri Mar 2010

Doubling Of Childhood Leukemia Rates In Southern Iraq Confirmed By International Study

Categorie : Lymphoma / Leukemia
Childhood leukemia rates have more than doubled over the last 15 years in the southern Iraq province of Basrah, according to the study, "Trends in Childhood Leukaemia in Basrah, Iraq (1993-2007), published in the American Journal of Public Health... ...

read more Childhood leukemia rates have more than doubled over the last 15 years in the southern Iraq province of Basrah, according to the study, read more Fri Mar 2010

New Cancer Treatment Gives Hope To Lymphoma And Leukemia Patients

Categorie : Lymphoma / Leukemia
Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia. PCI-32765 is a new drug being assessed in a Phase I clinical trial at the Virginia G. Piper Cancer Center in collaboration with the Clinical Division of the Translational Genomics Research ...

read more Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia. PCI-32765 is a new drug being assessed in a Phase I clinical trial at the Virginia G. Piper Cancer Center in collaboration with the Clinical Division of the Translational Genomics Research read more Fri Mar 2010

Vion Pharmaceuticals Receives Response From FDA On Special Protocol Assessment For Onrigin(TM)

Categorie : Lymphoma / Leukemia
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VIONQ) announced that it had received a response from the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment ("SPA") for its oncology therapeutic Onrigin™ (laromustine) Injection... ...

read more VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VIONQ) announced that it had received a response from the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment ( read more Fri Mar 2010

1 | 2 | 3 | 4 next >>>

eHealth Guide News Abortion ADHD Aid / Disasters Alcohol / Addiction Allergy Alzheimer's Anxiety Arthritis Asthma / Respiratory Autism Bio-terrorism / Terrorism Biology / Biochemistry Bipolar Bird Flu / Avian Flu Blood / Hematology Body Aches Bones / Orthopaedics Breast Cancer Cancer / Oncology Cardiovascular / Cardiology Caregivers / Homecare Cholesterol CJD / vCJD / Mad Cow Disease Cleft Palate Clinical Trials / Drug Trials Colorectal Cancer Complementary Medicine / Alternative Medicine Compliance Conferences Cosmetic Medicine / Plastic Surgery Crohn's Cystic Fibrosis Dentistry Depression Dermatology Diabetes Dyslexia Ear, Nose and Throat Endocrinology Epilepsy Erectile Dysfunction / Premature Ejaculation Eye Health / Optometry Fertility Flu / SARS GastroIntestinal Genetics Gout Headache / Migraine Health Insurance / Medical Insurance Hearing / Deafness HIV / AIDS Huntingtons Disease Hypertension Immune System / Vaccines Infectious Diseases / Bacteria / Viruses Irritable-Bowel Syndrome Liver Disease / Hepatitis Lung Cancer Lupus Lymphoma / Leukemia Medical Devices Medical Malpractice / Litigation Medical Students Medicare / Medicaid / Tricare Men's health Mental Health MRI / PET / Ultrasound MRSA / Drug Resistance Multiple Sclerosis Muscular Dystrophy Neurology / Neuroscience Nursing Nutrition/Agriculture Obesity / Weight Loss / Fitness Pain / Anesthetics Parkinson's Disease Pediatrics Pharma Industry Pregnancy Primary Care / General Practice Prostate Psychology / Psychiatry Public Health Radiology / Nuclear Medicine Rehabilitation Schizophrenia Seniors / Aging Sexual Health / STDs Sleep / Sleep Disorders Smoking / Quit Smoking Sports Medicine / Fitness Statins Stem Cell Research Stroke / Neuroprotection Transplants / Organ Donations Tropical Diseases Urology / Nephrology Veterinary Water Quality / Air Quality Women's Health / OBGYN Health Policy Health Jobs Listing

Health - Update.Pk